Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.
Condition(s):Pancreatic Ductal Adenocarcinoma; Colorectal CancerLast Updated:August 24, 2022Withdrawn